Follow Us:

GST Council in its56th Meeting has recommended significant changes to the GST rates for goods in the health sector. The proposed changes would reduce or remove the tax on a range of medicines and medical products. A number of specific, high-cost drugs, including those used for rare diseases, are slated for a reduction in tax from 12% to Nil. Certain other drugs will also see their rate go from 5% to Nil. In addition, a broad category of goods, including most drugs, diagnostic kits, surgical items, spectacles, and various medical instruments, would see their rate reduced from 12% to 5%. Medical thermometers and some analytical instruments would also be taxed at a lower rate, moving from 18% to 5%. These recommendations would lower the tax burden on a wide array of healthcare-related items.

Recommendations for HEALTH SECTOR

(5% to Nil)

S. No. Chapter / Heading / Sub-heading / Tariff item Description of Goods
1. 30
1 Agalsidase Beta
2 Imiglucerase
3 Eptacog alfa activated recombinant coagulation factor VIIa

 

(12% to Nil)

S. No. Chapter / Heading / Sub-heading / Tariff item Description of Goods
1. 30
1 Onasemnogene abeparvovec
2 Asciminib
3 Mepolizumab
4 Pegylated Liposomal Irinotecan
5 Daratumumab
6 Daratumumab subcutaneous
7 Teclistamab
8 Amivantamab
9 Alectinib
10 Risdiplam
11 Obinutuzumab
12 Polatuzumab vedotin
13 Entrectinib
14 Atezolizumab
15 Spesolimab
16 Velaglucerase Alpha
17 Agalsidase Alfa
18 Rurioctocog Alpha Pegol
19 Idursulphatase
20 Alglucosidase Alfa
21 Laronidase
22 Olipudase Alfa
23 Tepotinib
24 Avelumab
25 Emicizumab
26 Belumosudil
27 Miglustat
28 Velmanase Alfa
29 Alirocumab
30 Evolocumab
31 Cystamine Bitartrate
32

 

CI-Inhibitor injection
33 Inclisiran

 

(12% to 5%)

S. No. Chapter / Heading / Sub-heading / Tariff item Description of Goods
1. 28 Anaesthetics
2. 28 Potassium Iodate
3. 28 Steam
4. 2801 20 Iodine
5. 2804 40 10 Medical grade oxygen
6. 2847 Medicinal grade hydrogen peroxide
7. 30 All Drugs and medicines including:

(i) Fluticasone Furoate + Umeclidinium + Vilanterol FF/UMEC/VI

(ii) Brentuximab Vedotin

(iii) Ocrelizumab

(iv) Pertuzumab

(v) Pertuzumab + trastuzumab

(vi) Faricimab

8. 3001 Glands and other organs for organo-therapeutic uses, dried, whether or not powdered; extracts of glands or other organs or of their secretions for organo-therapeutic uses; heparin and its salts; other human or animal substances prepared for therapeutic or prophylactic uses, not elsewhere specified or included
9. 3002 Animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; toxins, cultures of micro-organisms (excluding yeasts) and similar products
10. 3003 Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale, including Ayurvaedic, Unani, Siddha, homoeopathic or Bio-chemic systems medicaments
11. 3004 Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, including Ayurvaedic, Unani, homoeopathic siddha or Bio-chemic systems medicaments, put up for retail sale
12 3005 Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes
14. 3006 Pharmaceutical goods specified in Note 4 to this Chapter [i.e. Sterile surgical catgut, similar sterile suture materials (including sterile absorbable surgical or dental yarns) and sterile tissue adhesives for surgical wound closure; sterile laminaria and sterile laminaria tents; sterile absorbable surgical or dental haemostatics; sterile surgical or denatal adhesion barriers, whether or not absorbable; Waste pharmaceuticals] [other than contraceptives and Ostomy appliances]
15. 3822 All diagnostic kits and reagents
16. 4015 Surgical rubber gloves or medical examination rubber gloves
17. 90 or any other Chapter Blood glucose monitoring system (Glucometer) and test strips
18. 90 or any other Chapter Patent Ductus Arteriousus / Atrial Septal Defect occlusion device
19. 9004 Spectacles and goggles for correcting vision
20. 9018 Instruments and appliances used in medical, surgical, dental or veterinary sciences, including scintigraphic apparatus, other electro-medical apparatus and sight-testing instruments
21. 9019 Mechano-therapy appliances; massage apparatus; psychological aptitude-testing apparatus; ozone therapy, oxygen therapy, aerosol therapy, artificial respiration or other therapeutic respiration apparatus
22. 9020 Other breathing appliances and gas masks, excluding protective masks having neither mechanical parts nor replaceable filters
23. 9022 Apparatus based on the use of X-rays or of alpha, beta or gamma radiations, for medical, surgical, dental or veterinary uses, including radiography or radiotherapy apparatus, X-ray tubes and other X-ray generators, high tension generators, control panels and desks, screens, examinations or treatment tables, chairs and the light
24. 9804 Other Drugs and medicines intended for personal use

( 18% to 5%)

S. No. Chapter / Heading / Sub-heading / Tariff item Description of Goods
1. 9025 Thermometers for medical, surgical, dental or veterinary usage
2. 9027 Instruments and apparatus for medical, surgical, dental or veterinary uses for physical or chemical analysis.

Note: The recommendations of the GST Council have been presented in this article containing major item of decisions in simple language for information of the stakeholders. The same would be given effect through the relevant circulars/ notifications/ law amendments which alone shall have the force of law. The author is not promoting or confirms or guarantee the final decision of the government to implement these recommendations and same shouldn’t be a cause of action against author to held responsible for any loss by using this information.

Join Taxguru’s Network for Latest updates on Income Tax, GST, Company Law, Corporate Laws and other related subjects.

Leave a Comment

Your email address will not be published. Required fields are marked *

Ads Free tax News and Updates
Search Post by Date
April 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
27282930